32.98 USD
▼-0.13-0.39%
盘后 32.34 -1.94%
2026-11-19
市值
$1.91B
市盈率
10.78
EPS
3.02
股息率
—
52 周区间
25.90 – 43.49
成交量
804.70K
Beta
0.98
目标价
48.08
52W 低 25.9052W 高 43.49
价格走势
公司简介
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also develops Pitolisant that is in Phase 3 clinical trial for the treatment of Prader-Willi Syndrome (PWS); in Phase 2 clinical trial to treat Myotonic Dystrophy (DM1); and is in P...